Inhibrx Biosciences
INBX
#5628
Rank
โ‚น135.32 B
Marketcap
โ‚น9,195
Share price
2.43%
Change (1 day)
196.08%
Change (1 year)

Revenue for Inhibrx Biosciences (INBX)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of โ‚น0.11 Billion an increase over the revenue in the year 2024 that were of โ‚น17.15 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inhibrx Biosciences from 2023 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A-100%
2025 โ‚น0.11 B580.18%
2024 โ‚น17.15 M-87.25%
2023 โ‚น0.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA